%A Wu Hansheng, Huang Shujie, Zhuang Weitao, Ding Yu, Gao Zhen, Qiao Guibin %T m 6A methylation modification and lung cancer %0 Journal Article %D 2021 %J Journal of International Oncology %R 10.3760/cma.j.cn371439-20200722-00045 %P 225-230 %V 48 %N 4 %U {https://gjzlx.sdfmu.edu.cn/CN/abstract/article_10981.shtml} %8 2021-04-08 %X

The biological role of N6-methyladenine (m6A) methylation modification has been gradually identified, and it has shown increasing value in tumor. In recent years, with the accumulated explore of epigenetics in RNA modification, many studies have reported that m6A methylation modification contributes to development and progression of lung cancer. m6A-related modified regulator has potential application value as a clinical target for diagnosis and treatment of lung cancer.